{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T06:47:53Z","timestamp":1777877273843,"version":"3.51.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Colleges and Universities of Anhui Provincial Department of Education","award":["No. KJ2021ZD0033"],"award-info":[{"award-number":["No. KJ2021ZD0033"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-44229-6","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T23:04:02Z","timestamp":1773788642000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The FOXE1 rs965513 polymorphism: a pleiotropic risk locus associated with thyroid function, BRAFV600E mutation, and susceptibility to papillary thyroid cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"Wenran","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simei","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingmin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaming","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaqing","family":"Dou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"issue":"10","key":"44229_CR1","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/nrendo.2011.142","volume":"7","author":"YE Nikiforov","year":"2011","unstructured":"Nikiforov, Y. E. & Nikiforova, M. N. Molecular genetics and diagnosis of thyroid cancer. Nat. Rev. Endocrinol. 7(10), 569\u2013580. https:\/\/doi.org\/10.1038\/nrendo.2011.142 (2011).","journal-title":"Nat. Rev. Endocrinol."},{"issue":"21","key":"44229_CR2","doi-asserted-by":"publisher","first-page":"4618","DOI":"10.1158\/1078-0432.CCR-21-2138","volume":"28","author":"PI Poulikakos","year":"2022","unstructured":"Poulikakos, P. I., Sullivan, R. J. & Yaeger, R. Molecular pathways and mechanisms of BRAF in cancer therapy. Clin. Cancer Res. 28(21), 4618\u20134628. https:\/\/doi.org\/10.1158\/1078-0432.CCR-21-2138 (2022).","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"44229_CR3","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1186\/s12935-021-02405-w","volume":"21","author":"G Huang","year":"2021","unstructured":"Huang, G. et al. Epigenetic modification and BRAF gene mutation in thyroid carcinoma. Cancer Cell. Int. 21(1), 687. https:\/\/doi.org\/10.1186\/s12935-021-02405-w (2021).","journal-title":"Cancer Cell. Int."},{"key":"44229_CR4","doi-asserted-by":"publisher","first-page":"102205","DOI":"10.1016\/j.cbpa.2022.102205","volume":"71","author":"A Gunderwala","year":"2022","unstructured":"Gunderwala, A., Cope, N. & Wang, Z. Mechanism and inhibition of BRAF kinase. Curr. Opin. Chem. Biol. 71, 102205. https:\/\/doi.org\/10.1016\/j.cbpa.2022.102205 (2022).","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"1","key":"44229_CR5","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s12957-016-0979-1","volume":"14","author":"C Liu","year":"2016","unstructured":"Liu, C., Chen, T. & Liu, Z. Associations between BRAF(V600E) and prognostic factors and poor outcomes in papillary thyroid carcinoma: A meta-analysis. World J. Surg. Oncol. 14(1), 241. https:\/\/doi.org\/10.1186\/s12957-016-0979-1 (2016).","journal-title":"World J. Surg. Oncol."},{"key":"44229_CR6","doi-asserted-by":"publisher","unstructured":"Wei, X. et al. Risk and prognostic factors for BRAFV600E mutations in papillary thyroid carcinoma. Biomed. Res. Int. 2022, 9959649. https:\/\/doi.org\/10.1155\/2022\/9959649 (2022).","DOI":"10.1155\/2022\/9959649"},{"issue":"7","key":"44229_CR7","doi-asserted-by":"publisher","first-page":"e28824","DOI":"10.1016\/j.heliyon.2024.e28824","volume":"10","author":"C Zuo","year":"2024","unstructured":"Zuo, C. et al. Underlying effect of SMAD4 gene polymorphism on risk prediction of papillary thyroid carcinoma in Chinese population. Heliyon 10(7), e28824. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e28824 (2024).","journal-title":"Heliyon"},{"issue":"4","key":"44229_CR8","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/ng.339","volume":"41","author":"J Gudmundsson","year":"2009","unstructured":"Gudmundsson, J. et al. Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat. Genet. 41(4), 460\u2013464. https:\/\/doi.org\/10.1038\/ng.339 (2009).","journal-title":"Nat. Genet."},{"key":"44229_CR9","doi-asserted-by":"publisher","unstructured":"Figlioli, G. et al. Novel genome-wide association study-based candidate loci for differentiated thyroid cancer risk. J. Clin. Endocrinol. Metab. 99(10), E2084\u2013E2092. https:\/\/doi.org\/10.1210\/jc.2014-1734 (2014).","DOI":"10.1210\/jc.2014-1734"},{"issue":"8","key":"44229_CR10","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1002\/ijc.29557","volume":"137","author":"V Mancikova","year":"2015","unstructured":"Mancikova, V. et al. Thyroid cancer GWAS identifies 10q26.12 and 6q14.1 as novel susceptibility loci and reveals genetic heterogeneity among populations. Int. J. Cancer. 137(8), 1870\u20131878. https:\/\/doi.org\/10.1002\/ijc.29557 (2015).","journal-title":"Int. J. Cancer"},{"issue":"3","key":"44229_CR11","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1530\/ERC-19-0156","volume":"27","author":"J Morillo-Bernal","year":"2020","unstructured":"Morillo-Bernal, J., Fern\u00e1ndez, L. P. & Santisteban, P. FOXE1 regulates migration and invasion in thyroid cancer cells and targets ZEB1. Endocr. Relat. Cancer. 27(3), 137\u2013151. https:\/\/doi.org\/10.1530\/ERC-19-0156 (2020).","journal-title":"Endocr. Relat. Cancer"},{"issue":"1","key":"44229_CR12","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1210\/jc.2004-1358","volume":"90","author":"SS Trueba","year":"2005","unstructured":"Trueba, S. S. et al. PAX8, TITF1, and FOXE1 gene expression patterns during human development: New insights into human thyroid development and thyroid dysgenesis-associated malformations. J. Clin. Endocrinol. Metab. 90(1), 455\u2013462. https:\/\/doi.org\/10.1210\/jc.2004-1358 (2005).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"20","key":"44229_CR13","doi-asserted-by":"publisher","first-page":"7302","DOI":"10.1128\/MCB.00758-07","volume":"27","author":"I Cuesta","year":"2007","unstructured":"Cuesta, I., Zaret, K. S. & Santisteban, P. The forkhead factor FoxE1 binds to the thyroperoxidase promoter during thyroid cell differentiation and modifies compacted chromatin structure. Mol. Cell. Biol. 27(20), 7302\u20137314. https:\/\/doi.org\/10.1128\/MCB.00758-07 (2007).","journal-title":"Mol. Cell. Biol."},{"issue":"9","key":"44229_CR14","doi-asserted-by":"publisher","first-page":"e1000637","DOI":"10.1371\/journal.pgen.1000637","volume":"5","author":"I Landa","year":"2009","unstructured":"Landa, I. et al. The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1\/USF2 transcription factors. PLoS Genet. 5(9), e1000637. https:\/\/doi.org\/10.1371\/journal.pgen.1000637 (2009).","journal-title":"PLoS Genet."},{"issue":"19","key":"44229_CR15","doi-asserted-by":"publisher","first-page":"6128","DOI":"10.1073\/pnas.1506255112","volume":"112","author":"H He","year":"2015","unstructured":"He, H. et al. Multiple functional variants in long-range enhancer elements contribute to the risk of SNP rs965513 in thyroid cancer. Proc. Natl. Acad. Sci. USA. 112(19), 6128\u20136133. https:\/\/doi.org\/10.1073\/pnas.1506255112 (2015).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"44229_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/EO-21-0003","volume":"1","author":"PW Owens","year":"2021","unstructured":"Owens, P. W. et al. FOXE1 polymorphism rs965513 predisposes to thyroid cancer in a European cohort. Endocr. Oncol. 1(1), 1\u20138. https:\/\/doi.org\/10.1530\/EO-21-0003 (2021).","journal-title":"Endocr. Oncol."},{"issue":"3","key":"44229_CR17","doi-asserted-by":"publisher","first-page":"283","DOI":"10.5603\/EP.2017.0021","volume":"68","author":"D Kula","year":"2017","unstructured":"Kula, D. et al. Age at diagnosis and gender modify the risk of 9q22 and 14q13 polymorphisms for papillary thyroid carcinoma. Endokrynol Pol. 68(3), 283\u2013289. https:\/\/doi.org\/10.5603\/EP.2017.0021 (2017).","journal-title":"Endokrynol Pol."},{"issue":"3","key":"44229_CR18","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1089\/thy.2014.0431","volume":"25","author":"TI Rogounovitch","year":"2015","unstructured":"Rogounovitch, T. I. et al. The common genetic variant rs944289 on chromosome 14q13.3 associates with risk of both malignant and benign thyroid tumors in the Japanese population. Thyroid 25(3), 333\u2013340. https:\/\/doi.org\/10.1089\/thy.2014.0431 (2015).","journal-title":"Thyroid"},{"issue":"10","key":"44229_CR19","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.3390\/diagnostics12102495","volume":"12","author":"R Khan","year":"2022","unstructured":"Khan, R. et al. Analysis of rare alleles of miRNA-146a (rs2910164) and miRNA-34b\/c (rs4938723) as a prognostic marker in thyroid cancer in Pakistani population. Diagnostics. 12(10), 2495. https:\/\/doi.org\/10.3390\/diagnostics12102495 (2022).","journal-title":"Diagnostics"},{"issue":"5","key":"44229_CR20","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1089\/thy.2013.0274","volume":"24","author":"M Penna-Martinez","year":"2014","unstructured":"Penna-Martinez, M. et al. FOXE1 association with differentiated thyroid cancer and its progression. Thyroid 24(5), 845\u2013851. https:\/\/doi.org\/10.1089\/thy.2013.0274 (2014).","journal-title":"Thyroid"},{"key":"44229_CR21","doi-asserted-by":"publisher","unstructured":"Duffek, M. et al. Risk genetic polymorphism and haplotype associated with papillary thyroid cancer and their relation to associated diseases in Slovak population. Bratisl Lek Listy. 123(7). https:\/\/doi.org\/10.4149\/BLL_2022_075 (2022).","DOI":"10.4149\/BLL_2022_075"},{"issue":"3","key":"44229_CR22","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1073\/pnas.1619917114","volume":"114","author":"Y Wang","year":"2017","unstructured":"Wang, Y. et al. MYH9 binds to lncRNA gene PTCSC2 and regulates FOXE1 in the 9q22 thyroid cancer risk locus. Proc. Natl. Acad. Sci. USA. 114(3), 474\u2013479. https:\/\/doi.org\/10.1073\/pnas.1619917114 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"44229_CR23","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1136\/jmedgenet-2011-100586","volume":"49","author":"AM Jones","year":"2017","unstructured":"Jones, A. M. et al. Thyroid cancer susceptibility polymorphisms: Confirmation of loci on chromosomes 9q22 and 14q13, validation of a recessive 8q24 locus and failure to replicate a locus on 5q24. J. Med. Genet. 49(3), 158\u2013163. https:\/\/doi.org\/10.1136\/jmedgenet-2011-100586 (2017).","journal-title":"J. Med. Genet."},{"key":"44229_CR24","doi-asserted-by":"publisher","unstructured":"K\u00f6hler, A. et al. Genome-wide association study on differentiated thyroid cancer. J. Clin. Endocrinol. Metab. 98(10), E1674\u2013E1681. https:\/\/doi.org\/10.1210\/jc.2013-1941 (2013).","DOI":"10.1210\/jc.2013-1941"},{"issue":"12","key":"44229_CR25","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1089\/thy.2013.0102","volume":"23","author":"S Liyanarachchi","year":"2013","unstructured":"Liyanarachchi, S. et al. Cumulative risk impact of five genetic variants associated with papillary thyroid carcinoma. Thyroid 23(12), 1532\u20131540. https:\/\/doi.org\/10.1089\/thy.2013.0102 (2013).","journal-title":"Thyroid"},{"issue":"6","key":"44229_CR26","doi-asserted-by":"publisher","first-page":"4317","DOI":"10.1007\/s10528-023-10642-z","volume":"62","author":"R Hajian","year":"2024","unstructured":"Hajian, R., Javadirad, S. M. & Kolahdouzan, M. FOXE1 gene is a probable tumor suppressor gene with decreased expression as papillary thyroid cancers grow, and is absent in anaplastic thyroid cancers. Biochem. Genet. 62(6), 4317\u20134334. https:\/\/doi.org\/10.1007\/s10528-023-10642-z (2024).","journal-title":"Biochem. Genet."},{"key":"44229_CR27","doi-asserted-by":"publisher","first-page":"872527","DOI":"10.3389\/fendo.2022.872527","volume":"13","author":"S Li","year":"2022","unstructured":"Li, S. et al. The role of thyroglobulin in preoperative and postoperative evaluation of patients with differentiated thyroid cancer. Front. Endocrinol. (Lausanne). 13, 872527. https:\/\/doi.org\/10.3389\/fendo.2022.872527 (2022).","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"1","key":"44229_CR28","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1590\/2359-3997000000103","volume":"60","author":"AC Xavier","year":"2016","unstructured":"Xavier, A. C., Maciel, R. M., Vieira, J. G., Dias-da-Silva, M. R. & Martins, J. R. Insights into the posttranslational structural heterogeneity of thyroglobulin and its role in the development, diagnosis, and management of benign and malignant thyroid diseases. Arch. Endocrinol. Metab. 60(1), 66\u201375. https:\/\/doi.org\/10.1590\/2359-3997000000103 (2016).","journal-title":"Arch. Endocrinol. Metab."},{"issue":"4","key":"44229_CR29","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.3390\/ijms23042173","volume":"23","author":"N Plei\u0107","year":"2022","unstructured":"Plei\u0107, N. et al. Genome-wide association analysis and genomic prediction of thyroglobulin plasma levels. Int. J. Mol. Sci. 23(4), 2173. https:\/\/doi.org\/10.3390\/ijms23042173 (2022).","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"44229_CR30","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1136\/jmedgenet-2011-100063","volume":"48","author":"M Matsuse","year":"2011","unstructured":"Matsuse, M. et al. The FOXE1 and NKX2-1 loci are associated with susceptibility to papillary thyroid carcinoma in the Japanese population. J. Med. Genet. 48(9), 645\u2013648. https:\/\/doi.org\/10.1136\/jmedgenet-2011-100063 (2011).","journal-title":"J. Med. Genet."},{"issue":"1","key":"44229_CR31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/ijms22010025","volume":"22","author":"SC Credendino","year":"2020","unstructured":"Credendino, S. C. et al. FOXE1 gene dosage affects thyroid cancer histology and differentiation in vivo. Int. J. Mol. Sci. 22(1), 25. https:\/\/doi.org\/10.3390\/ijms22010025 (2020).","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"44229_CR32","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1093\/jnci\/djad265","volume":"116","author":"R Liu","year":"2024","unstructured":"Liu, R., Zhu, G., Tan, J., Shen, X. & Xing, M. Genetic trio of BRAF and TERT alterations and rs2853669TT in papillary thyroid cancer aggressiveness. J. Natl. Cancer Inst. 116(5), 694\u2013701. https:\/\/doi.org\/10.1093\/jnci\/djad265 (2024).","journal-title":"J. Natl. Cancer Inst."},{"issue":"3","key":"44229_CR33","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/ng.1046","volume":"44","author":"J Gudmundsson","year":"2012","unstructured":"Gudmundsson, J. et al. Discovery of common variants associated with low TSH levels and thyroid cancer risk. Nat. Genet. 44(3), 319\u2013322. https:\/\/doi.org\/10.1038\/ng.1046 (2012).","journal-title":"Nat. Genet."},{"issue":"1","key":"44229_CR34","doi-asserted-by":"publisher","first-page":"3981","DOI":"10.1038\/s41467-020-17718-z","volume":"11","author":"W Zhou","year":"2020","unstructured":"Zhou, W. et al. GWAS of thyroid stimulating hormone highlights pleiotropic effects and inverse association with thyroid cancer. Nat. Commun. 11(1), 3981. https:\/\/doi.org\/10.1038\/s41467-020-17718-z (2020).","journal-title":"Nat. Commun."},{"issue":"3","key":"44229_CR35","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.ajhg.2010.08.005","volume":"87","author":"V Panicker","year":"2010","unstructured":"Panicker, V. et al. A locus on chromosome 1p36 is associated with thyrotropin and thyroid function as identified by genome-wide association study. Am. J. Hum. Genet. 87(3), 430\u2013435. https:\/\/doi.org\/10.1016\/j.ajhg.2010.08.005 (2010).","journal-title":"Am. J. Hum. Genet."},{"issue":"6","key":"44229_CR36","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/j.ajhg.2008.04.019","volume":"82","author":"L Arnaud-Lopez","year":"2008","unstructured":"Arnaud-Lopez, L. et al. Phosphodiesterase 8B gene variants are associated with serum TSH levels and thyroid function. Am. J. Hum. Genet. 82(6), 1270\u20131280. https:\/\/doi.org\/10.1016\/j.ajhg.2008.04.019 (2008).","journal-title":"Am. J. Hum. Genet."},{"issue":"5","key":"44229_CR37","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1530\/EJE-10-1130","volume":"164","author":"M Medici","year":"2011","unstructured":"Medici, M. et al. A large-scale association analysis of 68 thyroid hormone pathway genes with serum TSH and FT4 levels. Eur. J. Endocrinol. 164(5), 781\u2013788. https:\/\/doi.org\/10.1530\/EJE-10-1130 (2011).","journal-title":"Eur. J. Endocrinol."},{"issue":"10","key":"44229_CR38","doi-asserted-by":"publisher","first-page":"17739","DOI":"10.1002\/jcp.28399","volume":"234","author":"J Ma","year":"2019","unstructured":"Ma, J. et al. FOXE1 supports the tumor promotion of Gli2 on papillary thyroid carcinoma by the Wnt\/\u03b2-catenin pathway. J. Cell. Physiol. 234(10), 17739\u201317748. https:\/\/doi.org\/10.1002\/jcp.28399 (2019).","journal-title":"J. Cell. Physiol."},{"issue":"12","key":"44229_CR39","doi-asserted-by":"publisher","first-page":"bqac158","DOI":"10.1210\/endocr\/bqac158","volume":"163","author":"G Lim","year":"2022","unstructured":"Lim, G. et al. Foxe1 deletion in the adult mouse is associated with increased thyroidal mast cells and hypothyroidism. Endocrinology 163(12), bqac158. https:\/\/doi.org\/10.1210\/endocr\/bqac158 (2022).","journal-title":"Endocrinology"},{"issue":"5","key":"44229_CR40","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1089\/thy.2018.0136","volume":"29","author":"A L\u00f3pez-M\u00e1rquez","year":"2019","unstructured":"L\u00f3pez-M\u00e1rquez, A., Fern\u00e1ndez-M\u00e9ndez, C., Recacha, P. & Santisteban, P. Regulation of Foxe1 by thyrotropin and transforming growth factor beta depends on the interplay between thyroid-specific, CREB and SMAD transcription factors. Thyroid 29(5), 714\u2013725. https:\/\/doi.org\/10.1089\/thy.2018.0136 (2019).","journal-title":"Thyroid"},{"key":"44229_CR41","doi-asserted-by":"publisher","first-page":"1608222","DOI":"10.3389\/fendo.2025.1608222","volume":"16","author":"W Zhang","year":"2025","unstructured":"Zhang, W., Zeng, S., Dou, J. & Yu, C. Value of a BRAFV600E and lymphocyte subset-based nomogram for discriminating benign lesions from papillary thyroid carcinoma in C-TIRADS 3 and higher nodules. Front. Endocrinol. (Lausanne). 16, 1608222. https:\/\/doi.org\/10.3389\/fendo.2025.1608222 (2025).","journal-title":"Front. Endocrinol. (Lausanne)"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44229-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44229-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44229-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T22:46:31Z","timestamp":1777589191000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44229-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["44229"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-44229-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]},"assertion":[{"value":"27 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13945"}}